Idexx Laboratories stock was rising sharply Monday, even as the S&P 500 and major indexes remained in the red. The Dow Jones ...
IDEXX (IDXX) stock jumped 12% in early trading Monday after the pet healthcare company issued a Q4 earnings report and 2025 ...
Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.
IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to ...
IDEXX Laboratories, Inc. ( NASDAQ: IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ET Brian McKeon - Chief Financial Officer Andrew Emerson - Senior Vice President, Corporate & ...
Idexx forecast revenue between $4.06 billion and $4.17 billion in 2025, in line with analysts' estimates of $4.14 billion. The company also guided for earnings per share in the range of $11.74 and $12 ...
IDEXX’s IDXX business continues to be dampened by currency impacts and uncertain macroeconomic conditions. The stock carries a Zacks Rank #4 (Sell) currently. In recent times, U.S. clinical ...
The S&P 500 fell 0.8% on Monday, Feb. 3, as investors reacted to tariffs on major U.S. trading partners while awaiting key earnings and labor market data.
Electric-vehicle maker Tesla and traditional auto manufacturers General Motors and Ford fall but claw back losses with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback